FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 201 through 250 of 324

BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES - SIC # 2836

Ticker Exchange Company Financial Reports SIC #
MRKR Nasdaq Marker Therapeutics, Inc. 2836
MTVA Nasdaq MetaVia Inc. 2836
MYGN Nasdaq Myriad Genetics, Inc. 2836
NBP Nasdaq NovaBridge Biosciences 2836
NCEL Nasdaq NewcelX Ltd. 2836
NCNA Nasdaq NuCana plc 2836
NERV Nasdaq Minerva Neurosciences, Inc. 2836
NEUP Nasdaq Neuphoria Therapeutics Inc. 2836
NKTR Nasdaq Nektar Therapeutics 2836
NNNN Nasdaq Anbio Biotechnology 2836
NRSN Nasdaq NeuroSense Therapeutics Ltd. 2836
NTHI Nasdaq NeOnc Technologies Holdings, Inc. 2836
NTRA Nasdaq Natera, Inc. 2836
NVAX Nasdaq Novavax, Inc. 2836
NVCT Nasdaq Nuvectis Pharma, Inc. 2836
OABI Nasdaq OmniAb, Inc. 2836
OBX Nasdaq Obsidian Therapeutics, Inc. 2836
OCUL Nasdaq Ocular Therapeutix, Inc. 2836
ODTX Nasdaq Odyssey Therapeutics, Inc. 2836
OFIX Nasdaq Orthofix Medical Inc. 2836
OGEN NYSE American Oragenics, Inc. 2836
OKUR Nasdaq OnKure Therapeutics, Inc. 2836
OKYO Nasdaq OKYO Pharma Limited 2836
OLMA Nasdaq Olema Pharmaceuticals, Inc. 2836
ONCY Nasdaq Oncolytics Biotech Inc. 2836
OPK Nasdaq OPKO Health, Inc. 2836
ORKA Nasdaq Oruka Therapeutics, Inc. 2836
OSTX NYSE American OS Therapies Incorporated 2836
OTLK Nasdaq Outlook Therapeutics, Inc. 2836
PACB Nasdaq Pacific Biosciences of California, Inc. 2836
PALI Nasdaq Palisade Bio, Inc. 2836
PASG Nasdaq Passage Bio, Inc. 2836
PBYI Nasdaq Puma Biotechnology, Inc. 2836
PGEN Nasdaq Precigen, Inc. 2836
PHIO Nasdaq Phio Pharmaceuticals Corp. 2836
PLX NYSE American Protalix BioTherapeutics, Inc. 2836
PLYX Nasdaq Polaryx Therapeutics, Inc. 2836
PMVP Nasdaq PMV Pharmaceuticals, Inc. 2836
PRLD Nasdaq Prelude Therapeutics Incorporated 2836
PRME Nasdaq Prime Medicine, Inc. 2836
PROK Nasdaq ProKidney Corp. 2836
PTGX Nasdaq Protagonist Therapeutics, Inc. 2836
PTHS NYSE American Pelthos Therapeutics Inc. 2836
PTN Nasdaq Palatin Technologies, Inc. 2836
PURR Nasdaq Hyperliquid Strategies Inc. 2836
PVLA Nasdaq Palvella Therapeutics, Inc. 2836
QURE Nasdaq uniQure N.V. 2836
RADX Nasdaq Radiopharm Theranostics Limited 2836
RANI Nasdaq Rani Therapeutics Holdings, Inc. 2836
RCKT Nasdaq Rocket Pharmaceuticals, Inc. 2836
Results 200 through 250 of 324